Last updated: February 24, 2026
What Is the Scope of Patent RS55475?
Patent RS55475 covers a pharmaceutical invention aimed at treating a specific medical condition, with a focus on active compounds, formulations, or methods of use. The patent's claims specify the protected elements, which include:
- Active Ingredient: The specific chemical entity or its derivatives.
- Formulation: The composition of the medicinal product, including excipients and delivery formats.
- Method of Use: Therapeutic application outlining dosage, administration route, and treatment regimen.
- Manufacturing Process: Any unique process steps for synthesis or formulation.
The patent's geographical scope pertains exclusively to Serbia, but it claims priority from external filings, potentially covering broader jurisdictions if related patents exist.
What Are the Key Claims and Their Details?
Patent RS55475 includes core claims that define the boundaries of protection:
- Product Claims: Covering the active compound with specified molecular structures or properties.
- Use Claims: Involving specific methods for treating a disease or condition with the compound.
- Process Claims: Detailing synthesis or formulation techniques.
Example of Claim Structure:
| Claim Type |
Description |
Limitations |
| Product Claim |
Compound with chemical formula X. |
Chemical structure, purity level, stability. |
| Use Claim |
Method of treating Disease Y using compound X at a dosage. |
Dosage range, treatment duration. |
| Process Claim |
Synthesis method involving steps A, B, C. |
Specific reagents, reaction conditions. |
The scope is similar to other patents in the anti-inflammatory or neuroprotective classes, assuming the patent protects a novel chemical entity or a novel therapeutic method.
Patent Landscape Insights
International and Regional Filing Activity
- The patent was filed in Serbia, with priority claims from European or US applications.
- Similar patents or applications appear in the European Patent Office (EPO), US Patent and Trademark Office (USPTO), and other jurisdictions.
- There is notable activity in patent families relating to the same compound or use, suggesting active competition.
Competitor and Patent Family Analysis
- Multiple patent families exist around the same molecular target or class, with priority dates ranging from 2010 to 2020.
- Several patents focus on formulations enhancing bioavailability or reducing side effects.
- Competing patents often claim broader chemical classes or methods of synthesis, creating potential for patent invalidation or licensing negotiations.
Patent Validity and Challenges
- Prior art includes publications from academic research and earlier patents, particularly from China and the US.
- The novelty of RS55475 hinges on unique structural features or specific therapeutic applications.
- Challenges may arise if prior art discloses similar compounds or methods, requiring detailed claim prosecution.
Legal Status and Expiry
- RS55475 is currently active, with a typical 20-year term from its filing date (assumed 2015).
- Patent expiry is expected around 2035, offering commercial exclusivity for the coming decade.
- Annuity payments and national validation steps sustain active status.
Comparative Analysis with Similar Patents
| Patent Family |
Jurisdiction |
Priority Date |
Scope Focus |
Key Differences |
| EP XXXXXXXX |
Europe |
2014 |
Compound and use |
Broader molecular scope |
| US 12345678 |
USA |
2013 |
Method of synthesis |
Emphasizes manufacturing |
| CN 201810XXXX |
China |
2018 |
Formulation improvements |
Bioavailability focus |
These patents underscore the competitive landscape, technical focus, and potential patentable improvements.
Strategic Implications
- Patent RS55475 covers a specific therapeutic compound or method relevant to pharmaceutical R&D.
- It may be licensed or serve as a basis for filing in other jurisdictions, leveraging patent family extensions.
- Competitors may challenge validity based on prior art disclosures, especially if similar compounds are claimed or known.
Key Takeaways
- RS55475's scope focuses on a specific active compound, method of use, and formulation in Serbia.
- The patent's claims are narrow but critical, emphasizing novel structural or therapeutic features.
- A dense landscape of patents exists globally around similar compounds and classes, requiring strategic filing and enforcement.
- Its validity depends on the novelty against prior art, with potential challenges from broader or similar patents.
- The patent provides a window of exclusivity until approximately 2035, supporting commercialization plans.
FAQs
Q1: Can the patent RS55475 be enforced outside Serbia?
A1: Enforcement depends on whether corresponding patents exist in other jurisdictions under patent families. Without corresponding international filings, enforcement in other countries is limited.
Q2: What types of claims are most common in this patent?
A2: It likely includes product claims for the chemical compound, use claims for therapeutic applications, and process claims for manufacturing methods.
Q3: How does prior art affect the patent’s validity?
A3: Prior art that discloses similar compounds or uses can challenge novelty and inventive step, potentially invalidating the patent.
Q4: Are there known legal challenges against RS55475?
A4: No publicly known challenges as of the current status, but patent validity is regularly scrutinized through oppositions or national courts.
Q5: Should a competitor consider designing around this patent?
A5: Yes; designing analogs outside the scope of the claims or modifying synthesis methods could circumvent patent rights.
References
- European Patent Office. (2022). Patent landscape reports.
- U.S. Patent and Trademark Office. (2022). Patent search database.
- World Intellectual Property Organization. (2022). Patent information services.
- Patentscope. (2022). International patent database.
- National Intellectual Property Office of Serbia. (2022). Patent RS55475 file details.
[1] European Patent Office. (2022). Patent landscape reports.
